{
    "title": "US makes new Alzheimer's drug more widely accessible",
    "url": "https://www.dailymail.co.uk/wires/afp/article-12273011/US-makes-new-Alzheimers-drug-widely-accessible.html",
    "date": "2023-07-06",
    "keywords": [
        "drug",
        "approval",
        "leqembi",
        "brain",
        "medicare",
        "treatment",
        "study",
        "decision",
        "governmentrun",
        "biogen",
        "decline",
        "disease",
        "percent",
        "memory",
        "carer",
        "resident",
        "alzheimer",
        "establishment",
        "house",
        "paris",
        "regulator",
        "thursday",
        "move",
        "public",
        "health",
        "insurance",
        "trial",
        "side",
        "food",
        "administration",
        "program",
        "portion",
        "year",
        "confirmatory",
        "teresa",
        "buracchio",
        "statement",
        "brookslasure",
        "administrator",
        "agency",
        "news",
        "country",
        "cost",
        "loss",
        "acuity",
        "lecanemab",
        "antibody",
        "beta",
        "protein",
        "shrinkage",
        "patient",
        "cure",
        "time",
        "independence",
        "joanne",
        "pike",
        "president",
        "ceo",
        "spouse",
        "eisai",
        "aduhelm",
        "efficacy",
        "donanemab",
        "worldwide",
        "dementia",
        "thinking",
        "ability",
        "simplest"
    ],
    "category": [
        "wires",
        "afp"
    ]
}